經濟通串流版 ET Net IQ Streaming - ETF簡況 ETF Basic information

Invesco Nasdaq Biotechnology ETF

基本資料

種類:	ETF
費用比率%:	0.19
資產淨值:	29.58
成立日期:	11/06/2021

分析

市值分佈:

79.78%
大市值

9.26%
中市值

3.82%
小市值

持股比例加總可能不達100%，原因包括ETF持有現金或衍生工具。

行業分佈

國家/地區分佈

投資組合

(更新時間： 07/03/2026 05:58)

總持有投資項目: 247

100%

10大 (46.59%)

代號	名稱	佔比% ▼	持有日期
RCKT	Rocket Pharmaceuticals	0.04	27/02/2026
VNDA	Vanda Pharmaceuticals	0.04	27/02/2026
LXEO	Lexeo Therapeutics	0.04	27/02/2026
LYEL	Lyell Immunopharma Inc	0.04	27/02/2026
MRVI	Maravai LifeSciences Holdings	0.04	27/02/2026
PACB	Pacific Biosciences of California	0.04	27/02/2026
ZVRA	Zevra Therapeutics	0.04	27/02/2026
KMDA	Kamada Ltd	0.04	27/02/2026
AQST	Aquestive Therapeutics	0.04	27/02/2026
SLDB	Solid Biosciences	0.04	27/02/2026
GLPG	Galapagos NV	0.04	27/02/2026
IVVD	Invivyd	0.03	27/02/2026
PRTA	Prothena Corp	0.03	27/02/2026
SIGA	SIGA Technologies	0.03	27/02/2026
ETON	Eton Pharmaceuticals	0.03	27/02/2026
RGNX	REGENXBIO	0.03	27/02/2026
FULC	Fulcrum Therapeutics	0.03	27/02/2026
TRDA	Entrada Therapeutics	0.03	27/02/2026
LRMR	Larimar Therapeutics	0.03	27/02/2026
ALT	Altimmune	0.03	27/02/2026

1 2 3 4 5 6 7 8 9 10 11 12 13

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.